Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

7002 results

Sort By:

Understanding the Preferences and Views of Older Adults on the Use of Geriatric and Objective Functional Assessments for Cancer Treatment Planning.

Study ID: NCT06652347
Start Date: 2025-02-21
End Date: 2026-11
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

Cancer care delivery

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

A Pivotal Phase II Clinical Trial of Utidelone Injection Plus Capecitabine in HER2-negative Breast Cancer Patients With Brain Metastases

Study ID: NCT06764940
Start Date: 2025-07-14
End Date: 2027-07-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

120

Intervention / Treatment

Curious

Utidelone in combination with capecitabine

Utidelone in combination with capecitabine

Utidelone in combination with capecitabine

Sponsor

Biostar Pharma, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures

Study ID: NCT04085887
Start Date: 2026-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

12

Intervention / Treatment

Panidumambi-Iratiye ௮00

Pinpoint-IR9000 endoscopic/handheld device

Explorer Air camera

PDE-NEO-II

Sponsor

Stanford University

Source: clinicaltrials.gov

Share:
Add to list

Prostate Tissue BioBank

Study ID: NCT06659614
Start Date: 2024-01-01
End Date: 2034-01
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment
Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Core Biopsies for Establishing a Breast Tumor Tissue Repository

Study ID: NCT02250352
Start Date: 2013-11-14
End Date: 2027-11-14
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

400

Intervention / Treatment

cytology specimen collection procedure

Sponsor

University of Southern California

Source: clinicaltrials.gov

Share:
Add to list

Testing the Combination of Nivolumab and ASTX727 for Relapsed or Refractory B-Cell Lymphoma

Study ID: NCT05272384
Start Date: 2022-11-03
End Date: 2027-06-28
Study Type

Interventional

Study Phase

Phase1

No. of Participants

32

Intervention / Treatment

Biospecimen Collection

Computed Tomography

Decitabine and Cedazuridine

Nivolumab

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Interventional Radiology Liver Directed Therapies and Hypofractionated Image-Guided Radiation Therapy in Veteran and Non-Veteran, Non-surgical Hepatocellular Carcinoma Patients

Study ID: NCT04933435
Start Date: 2020-11-12
End Date: 2027-02
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

78

Intervention / Treatment

Quality of life questionnaires

Sponsor

Duke University

Source: clinicaltrials.gov

Share:
Add to list

Neoadjuvant SGLT2 Inhibition in Localized Prostate Cancer

Study ID: NCT04887935
Start Date: 2024-06-04
End Date: 2026-08-31
Study Type

Interventional

Study Phase

Phase1

No. of Participants

24

Intervention / Treatment

Dapagliflozin

Sponsor

Washington University School of Medicine

Source: clinicaltrials.gov

Share:
Add to list

An Investigational Scan (68Ga-PSMA-11 PET) for the Imaging of Prostate Cancer

Study ID: NCT04777071
Start Date: 2021-05-17
End Date: 2036-06-30
Study Type

Interventional

Study Phase

Phase2

No. of Participants

213

Intervention / Treatment

Computed Tomography

Gallium Ga 68 Gozetotide

Positron Emission Tomography

Magnetic Resonance Imaging

Bone Scan

Electronic Health Record Review

Sponsor

University of Washington

Source: clinicaltrials.gov

Share:
Add to list

A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer

Study ID: NCT04486352
Start Date: 2021-10-20
End Date: 2027-10
Study Type

Interventional

Study Phase

Phase2

No. of Participants

148

Intervention / Treatment

Atezolizumab - 28 Day Cycle

bevacizumab

Ipatasertib

Talazoparib

Trastuzumab emtansine

Tiragolumab

Atezolizumab - 21 Day Cycle

Involisib

Letrozole

Giredestrant

Abemaciclib

Sponsor

Alliance Foundation Trials, LLC.

Source: clinicaltrials.gov

Share:
Add to list